Skip to main content

ORAL HYPOGLYCEMIC MEDICATIONS

Tracking # 20-813927

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

THE MOST EFFECTIVE MANAGEMENT OF DIABETES MELLITUS DEMANDS AN INTERPROFESSIONAL APPROACH INVOLVING BOTH LIFESTYLE MODIFICATIONS WITH DIET AND EXERCISE AND PHARMACOLOGIC THERAPIES AS NECESSARY TO MEET INDIVIDUALIZED GLYCEMIC GOALS. LIFESTYLE MODIFICATIONS MUST BE COMBINED WITH ORAL PHARMACOLOGIC AGENTS FOR OPTIMAL GLYCEMIC CONTROL, PARTICULARLY AS TYPE 2 DIABETES MELLITUS PROGRESSES WITH CONTINUED LOSS OF PANCREATIC BETA-CELL FUNCTION AND INSULIN PRODUCTION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISMS OF ACTION, METHODS OF ADMINISTRATION, SIGNIFICANT ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF ORAL HYPOGLYCEMIC MEDICATIONS, SO PROVIDERS CAN DIRECT PATIENT THERAPY TO OPTIMAL OUTCOMES WHERE GLYCEMIC CONTROL AND DIABETES PLAY A ROLE IN OUTCOMES.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I